Long-Read Sequencing Cost and Market: What to Expect

Long-read sequencing has moved from a specialized technique to a mainstream option for genomics research and clinical applications. The two dominant platforms, Pacific Biosciences (PacBio) and Oxford Nanopore Technologies (ONT), now offer read lengths and accuracy that were unattainable a decade ago. For students, researchers, analysts, and life-science professionals, understanding the cost structure and market dynamics of these platforms is essential for budgeting, platform selection, and project planning. This article provides a practical overview of current costs, factors that influence pricing, and market trends that will shape procurement decisions.

At a Glance: Platform Cost Comparison

The table below summarizes the key cost considerations for the two major long-read sequencing platforms. These figures represent general market observations and should be verified with current vendor quotes, as pricing changes frequently with technology updates and service provider competition.

The Current Cost Landscape

Historical Cost Trajectory

The cost of long-read sequencing has declined substantially since the technology first became commercially available. The first human genome sequenced with early technologies took nearly a decade to complete, but a full diploid human genome can now be sequenced in days [8]. This dramatic reduction in time and cost has been driven by improvements in throughput, chemistry, and computational methods.

The perception of high cost has been a barrier to adoption for long-read sequencing. Early platforms had high error rates and significant per-base costs, which limited their use to specialized applications [11]. However, recent advancements have produced highly accurate sequences while reducing costs, making the technology viable for a broader range of projects [11].

Current Pricing Structure

Instrument costs vary significantly between the two major platforms. PacBio systems require substantial capital investment, with the Revio system representing a major institutional commitment. Oxford Nanopore offers a range of instruments, from the portable MinION to the high-throughput PromethION, allowing laboratories to scale their investment according to project needs [10].

Per-sample costs depend on several factors including sequencing depth, library preparation method, and whether the work is done in-house or through a service provider. For human whole-genome sequencing, 30x high-fidelity coverage has become a common standard for comprehensive variant detection [9]. Titration studies suggest that 90 percent of automatically called variants can be identified using 15-fold coverage, which could reduce costs for some applications [9].

Service Provider Pricing

Commercial sequencing services offer an alternative to instrument purchase. Service pricing varies widely based on throughput commitments, turnaround time, and the specific platform used. Core facilities at academic institutions often provide subsidized pricing for internal users while charging external users commercial rates.

When comparing service providers, researchers should request detailed quotes that include library preparation, sequencing, and initial bioinformatics support. Some providers offer discounted pricing for large batches or ongoing collaborations. The total cost of a project should include data storage and compute time for analysis, which can be substantial for long-read datasets.

Factors Influencing Long-Read Sequencing Costs

Sequencing Depth and Coverage

The required sequencing depth is the primary driver of per-sample cost. Higher coverage provides more confidence in variant calls but increases the number of flow cells or SMRT cells needed. For clinical applications where sensitivity is critical, 30x HiFi coverage has become a common standard [9]. Research projects with less stringent requirements may use lower coverage to reduce costs.

Coverage requirements also depend on the type of variants being investigated. Structural variant detection may require different depth than single-nucleotide variant calling. Projects targeting repeat expansions or complex genomic regions may need additional coverage to achieve reliable results [9].

Library Preparation Methods

Library preparation costs vary by method and application. Standard whole-genome library preparation is relatively straightforward, but specialized applications add cost. Targeted sequencing approaches can reduce overall project cost by focusing sequencing effort on specific genomic regions [20]. Long PCR amplification of target regions followed by nanopore sequencing has been shown to be a cost-effective approach for methylation analysis [20].

RNA sequencing requires additional steps for cDNA synthesis and may involve targeted enrichment. Methods such as TEQUILA-seq have been developed as low-cost approaches for targeted long-read RNA sequencing [23]. These methods reduce the amount of sequencing required by focusing on transcripts of interest.

Bioinformatics and Compute Costs

The computational demands of long-read sequencing are substantial. Basecalling raw signal data requires GPU-accelerated compute, particularly for nanopore data. Alignment and variant calling add additional compute requirements. Minimap2 provides efficient alignment for long reads and is substantially faster than earlier aligners, reducing compute costs [7].

De novo genome assembly remains computationally intensive. The quality of assemblies depends on sequencing depth, platform choice, and assembly tools [5]. Researchers should budget for sufficient compute resources or cloud computing costs when planning long-read projects.

Sample Throughput and Batching

The cost per sample decreases with higher throughput. Batching samples on a single flow cell or SMRT cell reduces the per-sample cost of consumables. Multiplexing with barcodes allows multiple samples to be sequenced together, though this may reduce per-sample coverage.

For small numbers of samples, service providers may be more cost-effective than instrument purchase. The break-even point depends on the instrument cost, consumable pricing, and the number of samples planned over the instrument lifetime.

Market Landscape and Key Players

Pacific Biosciences

PacBio has focused on high-accuracy long reads through its HiFi sequencing technology. The company has established a strong presence in human genomics, plant and animal genomics, and clinical research. PacBio HiFi reads provide accuracy comparable to short-read sequencing while maintaining long read lengths, making them suitable for detecting structural variants and resolving complex genomic regions [9].

The PacBio platform has been used for chromosome-level genome assembly in various species. A recent study assembled the genome of Chirolophis japonicus using PacBio HiFi long-reads combined with Hi-C and short-read data, achieving a contig N50 of 23.17 Mb [15]. This demonstrates the utility of PacBio data for producing high-quality reference genomes.

Oxford Nanopore Technologies

Oxford Nanopore has differentiated itself through the portability and scalability of its instruments. The MinION device enables sequencing in field settings, which has proven valuable for infectious disease outbreak response [21]. The technology supports both DNA and RNA sequencing directly, enabling applications such as direct RNA sequencing and metagenomics [10].

Nanopore sequencing has become a preferred option for many research teams due to its openness and versatility [10]. The technology has been applied to telomere-to-telomere genome assembly, pathogen detection, and environmental monitoring [10]. The ability to sequence long fragments without amplification preserves native modifications and simplifies certain analyses.

Emerging Players and Technologies

The long-read sequencing market continues to evolve with new entrants and technologies. Some startups have explored using short-read data to expand the long-read sequencing market [13]. These approaches aim to provide long-range information at lower cost by combining computational methods with existing short-read platforms.

Third-generation sequencing technologies continue to advance. Emerging methodologies include improvements in nanopore technology, in situ nucleic acid sequencing, and microscopy-based sequencing [6]. These developments may further reduce costs and expand applications.

Practical Workflow for Cost Assessment

Step 1: Define Project Requirements

Begin by clearly defining the biological question and the data needed to answer it. Consider the types of variants or features of interest, the required sensitivity and specificity, and the number of samples. This assessment determines the sequencing platform, depth, and throughput needed.

For clinical applications, consider whether the test will be used for diagnosis or research. Diagnostic applications may require higher standards of validation and documentation, which can increase costs [11]. Research applications may have more flexibility in coverage and quality thresholds.

Step 2: Compare Platform Options

Evaluate both PacBio and Oxford Nanopore for the specific application. Consider read length requirements, accuracy needs, and whether native base modification detection is needed. Both platforms can detect base modifications, but the methods and accuracy differ [11].

For structural variant detection, both platforms offer advantages over short-read sequencing. Long reads can span repetitive regions and resolve complex rearrangements that are difficult or impossible to detect with short reads [6]. The choice between platforms may depend on the specific variant types of interest and the bioinformatics tools available.

Step 3: Obtain Detailed Quotes

Request quotes from multiple service providers and instrument vendors. Include all costs: library preparation, sequencing, data storage, and bioinformatics support. Ask about volume discounts and turnaround time guarantees.

When comparing quotes, verify that the proposed coverage and quality metrics meet project requirements. Some providers may offer lower prices with reduced coverage or quality, which may not be suitable for all applications.

Step 4: Calculate Total Project Cost

Develop a comprehensive budget that includes all components of the project. Include costs for sample collection and processing, library preparation, sequencing, data storage, compute time, and personnel. Factor in the cost of validation experiments and any follow-up analyses.

For de novo assembly projects, budget for multiple rounds of sequencing if initial coverage is insufficient. Assembly quality depends on sequencing depth and platform choice, and some genomes may require additional data to achieve chromosome-level assemblies [5].

Step 5: Plan for Data Management

Long-read sequencing generates large volumes of data that require substantial storage and compute resources. Plan for raw data storage, processed data storage, and backup systems. Consider the costs of cloud storage and compute if local infrastructure is insufficient.

Data sharing requirements may also affect costs. Funding agencies and journals increasingly require data deposition in public repositories such as NCBI [2]. Budget for the time and resources needed to prepare and submit data to appropriate repositories.

Records and Measurements for Cost Tracking

Key Metrics to Monitor

Track the following metrics to evaluate the cost-effectiveness of long-read sequencing projects:

Documentation Practices

Maintain detailed records of all sequencing runs, including instrument settings, flow cell lot numbers, and quality metrics. This documentation supports troubleshooting and provides data for future cost projections. Record any failed runs or quality issues that require resequencing, as these affect the true cost per sample.

For service provider projects, document the agreed-upon specifications and verify that deliverables meet these specifications. Retain records of any additional charges for repeat runs or supplementary sequencing.

Common Failure Patterns and Cost Implications

Underestimating Coverage Requirements

Projects that underestimate the coverage needed for reliable variant detection may require additional sequencing runs, increasing costs. This is particularly problematic for clinical applications where sensitivity is critical [9]. Pilot experiments with a small number of samples can help establish appropriate coverage before committing to large-scale sequencing.

Ignoring Bioinformatics Costs

The computational demands of long-read sequencing are often underestimated. Basecalling, alignment, and variant calling require substantial compute resources. Projects without adequate local infrastructure may incur significant cloud computing costs. Budget for these costs from the start of the project.

Choosing the Wrong Platform

Selecting a platform without considering the specific requirements of the application can lead to suboptimal results and wasted expenditure. For example, projects requiring native base modification detection may prefer nanopore sequencing, while projects requiring the highest accuracy may benefit from PacBio HiFi [11]. Evaluate platform capabilities against project needs before committing resources.

Inadequate Quality Control

Failure to implement appropriate quality control measures can result in data that does not meet project requirements. This may necessitate resequencing and additional costs. Implement quality checks at each stage of the workflow, from DNA extraction through final variant calling.

Quality and Reproducibility Considerations

Accuracy and Error Rates

Both PacBio and Oxford Nanopore have improved their accuracy substantially in recent years. HiFi sequencing provides high accuracy that is comparable to short-read sequencing for many applications [9]. Nanopore sequencing has also improved, though error profiles differ from PacBio and may require different analysis approaches [10].

The choice of sequencing platform affects the types of errors observed and the bioinformatics tools needed for analysis. Researchers should validate their analysis pipelines with appropriate reference samples to ensure reliable results.

Reproducibility Across Runs

Reproducibility is essential for clinical applications and for studies comparing samples across time or conditions. Standardize protocols and use reference samples to monitor performance across runs. Document any changes to protocols or reagents that could affect results.

For diagnostic applications, the development of standards for clinical applications remains an ongoing need [11]. Larger cohort studies may be required to establish the realistic boundaries of long-read sequencing clinical utility [11].

Data Sharing and Standards

Data sharing is increasingly expected for publicly funded research. The NIH Genomic Data Sharing Policy outlines expectations for data deposition and sharing [3]. The FAIR Guiding Principles provide a framework for making data findable, accessible, interoperable, and reusable [4].

Plan for data sharing from the start of the project. This includes budgeting for data preparation, metadata documentation, and submission to appropriate repositories. The EMBL-EBI Training program offers resources for data management and sharing [1].

Limitations and Interpretation Boundaries

Variant Detection Limitations

While long-read sequencing can detect most challenging variants, some limitations remain. A study of 145 clinically relevant variants found that automated callers identified 83 percent of variants, with another 10 percent visually apparent but not automatically detected [9]. Systematic challenges remained for 7 percent of variants, such as the detection of AG-rich repeat expansions [9].

These limitations should be considered when interpreting results. Negative results from long-read sequencing do not exclude the presence of all variant types. Additional testing may be needed for variants in complex genomic regions.

Assembly Challenges

De novo whole-genome assembly remains challenging despite advances in sequencing technology [5]. The quality of assemblies depends on sequencing depth, platform choice, and assembly tools. Computational demands for assembly are substantial and should be factored into project budgets.

For complex genomes with high repeat content or polyploidy, additional sequencing may be needed to achieve chromosome-level assemblies. Pilot assemblies with a subset of data can help estimate the total data needed before committing to full-scale sequencing.

Clinical Validation Requirements

The use of long-read sequencing in clinical diagnostics requires validation to establish analytical validity and clinical utility [11]. This validation process adds cost and time to clinical implementation. The argument for increased diagnostic yield from long-read sequencing remains to be validated in larger cohort studies [11].

Laboratories considering clinical implementation should review regulatory requirements and professional guidelines. The costs of validation studies, quality control procedures, and ongoing proficiency testing should be included in implementation budgets.

Safety and Regulatory Context

Data Privacy and Security

Genomic data requires careful handling to protect patient privacy and comply with regulations. The NIH Genomic Data Sharing Policy outlines expectations for data security and access controls [3]. Researchers should implement appropriate data security measures and obtain necessary approvals before collecting and analyzing human genomic data.

For clinical applications, additional regulatory requirements may apply. Laboratories should consult with institutional review boards and regulatory authorities to ensure compliance with applicable laws and guidelines.

Biosafety Considerations

Sequencing facilities must follow appropriate biosafety practices for handling biological samples. This includes proper sample storage, handling, and disposal procedures. Researchers should follow institutional biosafety guidelines and any applicable regulations for the types of samples being processed.

For infectious disease applications, additional precautions may be needed. The portability of nanopore devices has enabled sequencing in field settings during outbreaks, but this requires appropriate biosafety measures [21].

Professional Escalation Criteria

When to Consult Specialists

Several situations warrant consultation with specialized experts:

• Complex de novo assembly projects that require specialized bioinformatics expertise
• Clinical diagnostic applications that require validation and regulatory approval
• Projects involving unusual sample types or challenging genomic regions
• Situations where standard analysis pipelines fail to produce reliable results

When to Consider Alternative Approaches

Consider alternative approaches when long-read sequencing does not provide the needed information or when costs are prohibitive. Short-read sequencing remains appropriate for many applications and may be more cost-effective for projects that do not require long-range information [6].

Hybrid approaches that combine short-read and long-read data may provide a balance of cost and capability for some projects. These approaches can reduce costs while providing the benefits of long reads for specific applications.

When to Escalate Quality Issues

Escalate quality issues when sequencing runs consistently fail to meet quality thresholds or when results are not reproducible. This may indicate problems with sample preparation, sequencing chemistry, or analysis pipelines. Consult with vendor technical support and consider external quality assessment programs.

For clinical applications, any quality issues that could affect patient care should be escalated immediately. Laboratories should have procedures in place for reporting and investigating quality failures.

Market Trends and Future Directions

Declining Costs and Increasing Accessibility

The cost of long-read sequencing continues to decline, making the technology increasingly accessible [11]. This trend is expected to continue as sequencing chemistry improves and throughput increases. Population-scale long-read sequencing projects are becoming feasible, with the first such studies emerging over the past two years [19].

The increasing accessibility of long-read sequencing has implications for research and clinical practice. As costs decline, long-read approaches may become the standard for certain applications, particularly those requiring structural variant detection or complex genome assembly [12].

Expansion of Applications

Long-read sequencing is being applied to an expanding range of problems. In infectious disease, long-read sequencing has revolutionized pathogen surveillance by enabling real-time genomic analysis for outbreak response [21]. In conservation, targeted sequencing approaches are being used to trace wildlife trafficking networks [18].

Agricultural and food safety applications are also emerging. Long-read sequencing can support the detection of genetic modifications in food products and the monitoring of antimicrobial resistance determinants [14][17]. These applications may drive further market growth and cost reductions.

Integration with Other Technologies

The integration of long-read sequencing with other genomic technologies is expanding the range of possible applications. Combining long-read sequencing with Hi-C data enables chromosome-level genome assembly [15]. Integration with single-cell and spatial technologies is providing new insights into gene regulation [16].

These integrated approaches may increase the value of long-read sequencing while also increasing the complexity and cost of projects. Researchers should consider whether integrated approaches are needed to answer their biological questions.

Budget Planning Guide

Estimating Costs for Different Project Types

The following considerations apply to common project types:

Human whole-genome sequencing: Budget for 30x HiFi coverage for comprehensive variant detection [9]. Consider whether reduced coverage at 15x is sufficient for the specific application, as this can substantially reduce costs [9].

De novo genome assembly: Budget for sufficient coverage to achieve the desired assembly quality. Chromosome-level assemblies typically require additional data, including Hi-C or other scaffolding data [15]. Pilot assemblies can help estimate total data needs.

Targeted sequencing: Consider targeted approaches to reduce costs when only specific genomic regions are of interest. Long PCR amplification followed by nanopore sequencing has been shown to be cost-effective for targeted methylation analysis [20].

RNA sequencing: Budget for cDNA synthesis and any targeted enrichment steps. Long-read RNA sequencing provides full-length transcript information that is not available from short-read approaches [7].

Strategies for Cost Reduction

Several strategies can reduce the cost of long-read sequencing projects:

• Batch samples to maximize flow cell utilization
• Use targeted sequencing approaches when appropriate
• Consider reduced coverage for applications where it is sufficient
• Compare service provider pricing and negotiate volume discounts
• Use open-source bioinformatics tools to reduce software costs
• Plan data management to minimize storage and compute costs

Contingency Planning

Include contingency funds in project budgets for unexpected costs. Common contingencies include:

• Failed sequencing runs that require repetition
• Additional sequencing needed to achieve coverage targets
• Extended bioinformatics analysis time
• Data storage costs exceeding initial estimates

Frequently Asked Questions

What is the current cost per human genome for long-read sequencing?

The cost per human genome for long-read sequencing varies by platform, coverage, and service provider. PacBio HiFi sequencing at 30x coverage is more expensive than short-read whole-genome sequencing but provides additional information for structural variant detection and complex region resolution [9]. Oxford Nanopore offers lower entry costs but may require higher coverage for some applications. Service provider pricing should be obtained for current rates.

How does PacBio compare to Oxford Nanopore in terms of cost?

PacBio systems require higher capital investment but provide high-accuracy HiFi reads. Oxford Nanopore offers lower instrument costs and scalable consumable purchases, making it accessible to smaller laboratories [10]. The total cost of a project depends on the number of samples, required coverage, and bioinformatics needs. Both platforms have reduced costs substantially in recent years [11].

Can long-read sequencing replace short-read sequencing?

Long-read sequencing can detect many variants that are challenging for short-read sequencing, including structural variants and variants in repetitive regions [6]. However, short-read sequencing remains appropriate for many applications and may be more cost-effective for projects that do not require long-range information [6]. Some projects may benefit from combining both approaches.

What factors most significantly affect long-read sequencing costs?

The most significant cost factors are sequencing depth, platform choice, and the number of samples. Library preparation methods and bioinformatics requirements also contribute to total costs. Targeted sequencing approaches can reduce costs by focusing on specific genomic regions [20]. Service provider pricing varies by region and volume commitments.

How much bioinformatics compute is needed for long-read data?

Long-read sequencing requires substantial compute resources for basecalling, alignment, and variant calling. Minimap2 provides efficient alignment for long reads and is substantially faster than earlier aligners [7]. De novo assembly is particularly compute-intensive [5]. Researchers should budget for adequate compute resources or cloud computing costs.

Are there cost-effective approaches for targeted long-read sequencing?

Yes, targeted approaches can substantially reduce costs by focusing sequencing on specific genomic regions. Long PCR amplification followed by nanopore sequencing has been shown to be cost-effective for targeted methylation analysis [20]. Methods such as TEQUILA-seq provide low-cost options for targeted long-read RNA sequencing [23].

How do service provider prices compare to in-house sequencing?

Service provider pricing can be competitive with in-house sequencing, particularly for small numbers of samples. In-house sequencing requires capital investment in instruments and ongoing costs for consumables, maintenance, and personnel. The break-even point depends on the number of samples and the specific platform. Service providers may offer volume discounts for large projects.

What should be included in a long-read sequencing budget?

A complete budget should include sample collection and processing, library preparation, sequencing, data storage, compute time, and personnel. Include costs for validation experiments and any follow-up analyses. Plan for data management and sharing requirements, including submission to public repositories such as NCBI [2]. Include contingency funds for unexpected costs.

Related Bioinformatics Guides

• Long-Read Sequencing Technologies: PacBio and Oxford Nanopore
• Basecalling Algorithms for Nanopore Sequencing
• Long-Read Genome Assembly and Polishing Strategies
• Nanopore Adaptive Sampling for Targeted Pathogen Sequencing
• Long Read Metagenomic Assembly: Structural Analysis and Computational Methodologies in Bioinformatics

References and Further Reading

• EMBL-EBI Training. European Bioinformatics Institute.
• NCBI Data Resources. National Center for Biotechnology Information.
• Genomic Data Sharing Policy. National Institutes of Health.
• The FAIR Guiding Principles. Scientific Data.
• Advancements in long-read genome sequencing technologies and algorithms.. Genomics, 2024.
• Next-Generation Sequencing and Emerging Technologies.. Seminars in thrombosis and hemostasis, 2024.
• Minimap2: pairwise alignment for nucleotide sequences.. Bioinformatics (Oxford, England), 2018.
• Next-Generation Sequencing Technologies.. Cold Spring Harbor perspectives in medicine, 2019.
• HiFi long-read genomes for difficult-to-detect, clinically relevant variants.. American journal of human genetics, 2025.
• Nanopore sequencing: flourishing in its teenage years.. Journal of genetics and genomics = Yi chuan xue bao, 2024.
• Long-read sequencing for molecular diagnostics in constitutional genetic disorders.. Human mutation, 2022.
• Long-Read Sequencing: The Third Generation of Diagnostic Testing for Dystonia.. Movement disorders : official journal of the Movement Disorder Society, 2025.
• Startups use short-read data to expand long-read sequencing market.. 2015.
• Integrated Phenotypic and Sequencing-Based Resistome Assessment of Antimicrobial Resistance Determinants in a Sample of Commercial Farm-Animal Probiotic Products. 2026.
• Chromosome-level Genome assembly and annotation of the Chirolophis japonicus.. 2026.
• From Spatial Epigenomes to Clinical Diagnostics: Integrative Methylomics Across Scales and Modalities.. 2026.
• Application of SNV Detection Methods for Market Control of Food Products from New Genomic Techniques.. 2026.
• Targeted sequencing enhances detection of pangolin trafficking hotspots and dynamics of both domestic and global trade markets.. 2026.
• Towards population-scale long-read sequencing. Nature reviews genetics, 2021.
• Cost-effective promoter methylation analysis via target long-read bisulfite sequencing: a case study in severe preterm birth. BMC Medical Genomics, 2025.
• Long-Read Sequencing for the Rapid Response to Infectious Diseases Outbreaks. Current Clinical Microbiology Reports, 2025.
• Long-read sequencing settings for efficient structural variation detection based on comprehensive evaluation. BMC Bioinformatics, 2021.
• TEQUILA-seq: a versatile and low-cost method for targeted long-read RNA sequencing. Nature Communications, 2023.
• 16S rRNA long-read nanopore sequencing is feasible and reliable for endometrial microbiome analysis. Reproductive Biomedicine Online, 2021.
• Sequencing the unseen: long-read metagenomics and the microbial frontier. Computational Genomics and Structural Bioinformatics in Microbial Science Microbial Genomics Volume 2, 2025.

This article is educational and does not replace validated analysis plans, institutional policy, clinical interpretation, or specialist review.